Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's offering.
This report indicates that the Global Joint Pain Injections Market, valued at USD 1.10 billion in 2022, is anticipated to exhibit an impressive growth trajectory with a CAGR of 5.11% through to 2028; reaching USD 1.47 billion. As joint pain continues to affect a vast population worldwide, the market for joint pain injections is responding with advanced treatment options that offer both efficacy and convenience for sufferers.
Rising obesity rates globally constitute a major propellant for the joint pain injections market, with excess weight contributing significantly to joint stress, particularly in the knees, hips, and lower back, thereby heightening demand for non-surgical pain relief interventions.
The market is further energized by the increasing preference for minimally invasive treatments. Joint pain injections, being less invasive than traditional surgical methods, reduce recovery time, minimize risk of complications, and suit the fast-paced lifestyle of modern patients, therefore, serving as an attractive treatment modality.
Surge in Awareness and Patient-Centric Approaches Fuel Market Growth
Advancements in healthcare education and awareness have led to a more informed patient population exploring joint pain injections as a potential means for relief. With amplified knowledge, patients are now taking a proactive role in their treatment decisions, a fact that has contributed to an upswing in the market for joint pain injections.
Simultaneously, the tenets of patient-centric care are reflected within the joint pain injections market, as treatments are increasingly customized to fit individual patient circumstances and preferences. This focus on the patient's well-being and quality of life is a cornerstone of the market's expansion.
Market Challenges: Reimbursement Policies and Competition
While growth prospects are robust, the joint pain injections market is navigating through challenges such as reimbursement issues and pricing pressures owing to intense competition. These hurdles accentuate the need for inclusive insurance support and strategic responses to remain competitive and profitable.
Innovative Products and Regional Market Insights
- Advancements in Biologics and Regenerative Therapies: The development of sophisticated biologics, such as PRP injections, and regenerative therapies are poised to offer patients improved pain management solutions.
- AI and Data Analytics: Innovations in artificial intelligence and data analytics promise greater treatment optimization, enabling more personalized care plans.
- Regional Growth: North America continues to lead in the joint pain injections space, affirming its dominance owing to its advanced healthcare systems and solid presence of market players. However, regions like Asia-Pacific are emerging as significant growth areas on the global platform.
The comprehensive report delves into the dynamic market segments, including detailed analyses of various types of injections and applications, providing stakeholders with substantive insights. The strategic regional market perspectives offer a lens into the trends and developments propelling the joint pain injections market forward.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2022-2028 |
| Estimated Market Value (USD) in 2022 | $1.1 Billion |
| Forecasted Market Value (USD) by 2028 | $1.47 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes:
- Anika Therapeutics Inc.
- Bioventus LLC
- Ferring Pharmaceuticals Inc.
- Sanofi SA
- Pfizer Inc.
- Eli Lilly & Co.
- Flexion Therapeutics Inc.
- Teva Pharmaceutical Industries Ltd
- Zimmer Biomet Holdings, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/lego35
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
